X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77) 77
index medicus (74) 74
male (51) 51
female (49) 49
middle aged (47) 47
aged (45) 45
adult (38) 38
hepatitis c virus (33) 33
gastroenterology & hepatology (31) 31
interferon (29) 29
hepatitis (24) 24
hepatitis c (24) 24
human necessities (24) 24
hygiene (24) 24
medical or veterinary science (24) 24
analysis (23) 23
preparations for medical, dental, or toilet purposes (23) 23
virology (23) 23
infection (22) 22
treatment outcome (22) 22
liver (21) 21
animals (20) 20
care and treatment (20) 20
genotype (20) 20
health aspects (20) 20
ribavirin (20) 20
antiviral agents - therapeutic use (19) 19
risk factors (19) 19
aged, 80 and over (18) 18
gastroenterology (18) 18
hepacivirus - genetics (17) 17
hepatocellular-carcinoma (17) 17
hepatology (17) 17
drug therapy, combination (16) 16
hepatitis c, chronic - drug therapy (16) 16
polymorphism, single nucleotide (16) 16
genome-wide association (15) 15
genetic aspects (14) 14
medicine & public health (14) 14
mice (14) 14
antiviral agents - administration & dosage (13) 13
biological response modifiers (13) 13
colorectal surgery (12) 12
genetic-variation (12) 12
hepatocellular carcinoma (12) 12
infectious diseases (12) 12
medical research (12) 12
surgical oncology (12) 12
viruses (12) 12
young adult (12) 12
cirrhosis (11) 11
daclatasvir (11) 11
hcv (11) 11
hepacivirus - drug effects (11) 11
hepatitis b (11) 11
hepatitis c, chronic - genetics (11) 11
hepatoma (11) 11
liver cancer (11) 11
medicine, experimental (11) 11
microbiology (11) 11
oncology (11) 11
patients (11) 11
replication (11) 11
amino-acid substitutions (10) 10
asunaprevir (10) 10
cancer (10) 10
electricity (10) 10
gastroenterology and hepatology (10) 10
gene expression (10) 10
hepatitis c, chronic - virology (10) 10
interleukins - genetics (10) 10
japanese patients (10) 10
pharmacology & pharmacy (10) 10
plus ribavirin (10) 10
abdominal surgery (9) 9
development and progression (9) 9
disease (9) 9
drug resistance (9) 9
japan (9) 9
liver cirrhosis (9) 9
medicine (9) 9
prognosis (9) 9
research (9) 9
rna (9) 9
chemistry (8) 8
combination therapy (8) 8
deoxyribonucleic acid--dna (8) 8
electric communication technique (8) 8
fibrosis (8) 8
genome-wide association study (8) 8
genotypes (8) 8
hepatitis b virus (8) 8
human hepatocyte chimeric mouse (8) 8
liver diseases (8) 8
metallurgy (8) 8
pictorial communication, e.g. television (8) 8
ribavirin - therapeutic use (8) 8
single-nucleotide polymorphism (8) 8
therapy (8) 8
usage (8) 8
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (239) 239
Japanese (19) 19
French (12) 12
Chinese (5) 5
German (5) 5
Spanish (3) 3
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Engineering Fracture Mechanics, ISSN 0013-7944, 10/2019, Volume 220, p. 106652
Fracture toughness experiments were conducted on ~ 500-nm-thick copper films with a thickness-controlled surface oxide layer and without an oxide layer. The... 
Copper | Surface oxide layer | Thin film | Fracture toughness
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2011, Volume 204, Issue 1, pp. 84 - 93
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2017, Volume 52, Issue 4, pp. 504 - 511
Daclatasvir and asunaprevir combination therapy has shown a high virological response for chronic genotype 1 hepatitis C virus (HCV)-infected patients.... 
Daclatasvir | Chronic hepatitis C | Medicine & Public Health | Resistance-associated variants | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Older patients | Asunaprevir | Surgical Oncology | UNITED-STATES | RIBAVIRIN | VIROLOGICAL RESPONSE | PEGINTERFERON | VIRUS GENOTYPE 1B | PLUS ASUNAPREVIR | PEGYLATED INTERFERON | NULL RESPONDERS | INFECTION | HCV | GASTROENTEROLOGY & HEPATOLOGY | Predictive Value of Tests | Isoquinolines - adverse effects | Age Factors | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Male | RNA, Viral - blood | Viral Load | Young Adult | Aged, 80 and over | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Hepacivirus - drug effects | Hepacivirus - isolation & purification | Drug Administration Schedule | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug Resistance, Viral - genetics | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Adolescent | Isoquinolines - therapeutic use | Sulfonamides - adverse effects | Aged | Polymorphism, Single Nucleotide | Sustained Virologic Response | Isoquinolines - administration & dosage | Sulfonamides - administration & dosage | Care and treatment | Analysis | Aged patients | Drug resistance | Hepatitis C virus | Hepatitis C | Health aspects | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 02/2011, Volume 60, Issue 2, pp. 261 - 267
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 2/2018, Volume 53, Issue 2, pp. 269 - 280
The risk factors in the progression of nonalcoholic fatty liver disease (NAFLD) have not been fully clarified. Porphyromonas gingivalis (P.g) has been... 
Porphyromonas gingivalis | Medicine & Public Health | Colorectal Surgery | Hepatology | Metabolome analysis | Fatty acid | Gastroenterology | Abdominal Surgery | Non-alcoholic fatty liver disease | Non-alcoholic steatohepatitis | Surgical Oncology | FIBROSIS | METABOLIC SYNDROME | BACTERIA | PREDICTOR | PREVALENCE | GENOTYPES | STEATOHEPATITIS | JAPANESE PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | TYPE-2 DIABETES-MELLITUS | SEVERITY | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Age Factors | Immunoglobulin G - blood | Humans | Middle Aged | Diet, High-Fat - adverse effects | Male | Periodontitis - metabolism | Adult | Female | Bacteroidaceae Infections - metabolism | Antibodies, Bacterial - blood | Porphyromonas gingivalis - immunology | Disease Models, Animal | Bacteroidaceae Infections - complications | Periodontitis - immunology | Liver - metabolism | Mice, Inbred C57BL | Non-alcoholic Fatty Liver Disease - microbiology | Risk Factors | Non-alcoholic Fatty Liver Disease - metabolism | Disease Progression | Animals | Bacteroidaceae Infections - immunology | Biopsy | Aged | Periodontitis - complications | Fatty Acids - biosynthesis | Medical research | Fatty liver | Metabolites | Analysis | Alcoholics | Physiological aspects | Medicine, Experimental | Development and progression | Fatty acids | Risk factors | Liver diseases | Immunoglobulin G | Infections | Multivariate analysis | High fat diet | Steatosis | Pili | Fibrosis | Enzyme-linked immunosorbent assay
Journal Article
Nature Genetics, ISSN 1061-4036, 10/2010, Volume 42, Issue 10, pp. 893 - 896
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 1/2018, Volume 53, Issue 1, pp. 107 - 118
Biomarkers predicting the response to the anticancer treatment and prognosis in patients with advanced hepatocellular carcinoma (HCC) are required. Recently,... 
High mobility group box 1 | Liver cancer | Biomarker | Medicine & Public Health | Colorectal Surgery | Hepatic arterial infusion chemotherapy | Hepatology | Sorafenib | Gastroenterology | Abdominal Surgery | HCC | Surgical Oncology | VEIN TUMOR THROMBOSIS | APOPTOSIS | PROTEIN-KINASE-C | 5-FLUOROURACIL/INTERFERON COMBINATION THERAPY | GROUP BOX 1 | INTERFERON-ALPHA | PATHWAY | JAPANESE PATIENTS | GASTROENTEROLOGY & HEPATOLOGY | INTRAARTERIAL 5-FLUOROURACIL | PROGRESSION | Multivariate Analysis | Sorafenib - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Hepatic Artery | Male | Survival Rate | Antineoplastic Agents - administration & dosage | Disease Progression | Liver Neoplasms - blood | Young Adult | Carcinoma, Hepatocellular - pathology | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - blood | HMGB1 Protein - blood | Infusions, Intra-Arterial | Antimitotic agents | Medical research | Chemotherapy | Chromosomal proteins | Liver diseases | Analysis | Liver | Medicine, Experimental | Hepatoma | Antineoplastic agents | Cancer | Tumor markers | Hepatic vein | Medical prognosis | Hepatocellular carcinoma | Multivariate analysis | HMGB1 protein | Survival
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 11/2016, Volume 51, Issue 11, pp. 1073 - 1080
Journal Article